Lucarelli G, Isgro A, Sodani P, et al. Hematopoietic stem cell transplantation in thalassemia and sickle cell anemia. Cold Spring Harb Perspect Med 2012;2:a011825.
Angelucci E. Hematopoietic Stem Cell Transplantation in Thalassemia. ASH Education Book 2010;1:456-62.
Thomas ED, Buckner CD, Sanders JE, et al. Marrow transplantation for thalassaemia. Lancet 1982;2:227-9.
VanichsetakulP,WacharaprechanontT,O-CharoenR,etal. Umbilical cord blood transplantation in children with beta-thalassemia diseases. J Med Assoc Thai 2004;87:S62-7.
Old JM, Olivieri NF, Thein SL. Diagnosisandmanagement of thalassaemia. In: Weatherall DJ, Clegg JB eds. The Thalassaemia Syndromes, 4th ed. Oxford: Blackwell Science Ltd., 2001:663.
Rocha V, Wagner JE, Sobocinski KA, et al. Graft-versus- host disease in children who have received a cord blood or bone marrow transplant from an HLA-identical sibling. Eurocord and international bone marrow trans- plant registry working committee on alternative donor and stem cell sources. N Engl J Med 2000;342:1846-54.
Gluckman E. Hematopoietic stem cell transplants using umbilical cord blood. N Engl J Med 2001;344:1860-1.
WacharaprechanontT,O-CharoenR,VanichsetakulP,etal. Cord blood collection for the National Cord Blood Bank in Thailand. J Med Assoc Thai 2003;86:S409-16.
Ryu SG, Lee JH, Choi SJ,et al. Randomized comparison of four-times-dailyversusonce dailyintravenousbusulfan in conditioning therapy for hematopoietic cell transplan- tation. Biol Blood Marrow Transplant 2007;13:1095-105.
Nguyen L, Fuller D, Lennon S, et al. I.V. busulfan in pediatrics: a novel dosing to improve safety/efficacy for hematopoietic progenitor cell transplantation recipients. Bone Marrow Transplant 2004;33:979-87.
Vogelsang GB, Hess AD. Graft-versus-host disease: new directions for a persistent problem. Blood 1994;84:2061-7.
Glucksberg H, Storb R, Fefer A, et al. Clinical mani- festations of graft-versus-host disease in human recipients of marrow from HLA-matched sibling donors. Transplan- tation 1974;18:295-304.
Storb R, Prentice RL, Sullivan KM, et al. Predictive factors in chronic graft-versus-host disease in patients with aplastic anemia treated by bone marrow transplan- tation from HLA-identical siblings. Ann Intern Med 1983; 98:461-6.
Locatelli F, Percivalle E, Comoli P, et al. Human cyto megalovirus (HCMV) infection in pediatric patients- given allogeneic bone marrow transplantation: role of early treatment of antigenemia on patients’ outcome. Br J Haematol 1994;88:64-71.
Lucarelli G, Weatherall DJ. For debate: bone marrow transplantation for severe thalassaemia (1). The view from Pesaro (2). To be or not to be. Br J Haematol 1991;78:300-3.
Lucarelli G, Polchi P, Izzi T, et al. Allogeneic marrow transplantation for thalassemia. Exp Hematol 1984; 12:676-81.
Gaziev J, Sodani P, Lucarelli G. Hematopoietic stem cell transplantation in thalassemia. Bone Marrow Transplan- tation 2008;42:S41.
